As the U.S. backpedals on its mRNA investment, Mexico is embracing the technology through a new manufacturing pact with ...

Two and a half years after Sanofi unveiled to investors a revamped strategy to create an mRNA seasonal flu vaccine, Fierce Biotech has learned that the French pharma has put this pipeline on ice. The ...

Moderna — Shares tumbled 10% after the pharma giant said the Food and Drug Administration refused to review its application ...

A new personalized mRNA melanoma vaccine developed by Moderna and Merck is showing promising results, cutting the risk of cancer recurrence nearly in half for high-risk patients.

Moderna, Inc. vs. Novavax, Inc.: cost cuts, vaccine pipeline catalysts, and valuations. Click for this comparison of NVAX and MRNA and see which is better for you.

Acadia Healthcare — The health-care stock popped 10% after investor David Einhorn told CNBC that he has been buying the stock. The Greenlight Capital fund manager said he's hopeful the company's new ...

US stocks rallied on Wednesday as traders cheered a stronger-than-expected jobs report. The S&P 500 Index advanced 0.4% at 9.57am in New York, with the gauge headed for an all-time high.

Some periods of history are so bizarre that even if you’ve lived through them, looking back on them feels surreal, as though ...

On February 2, 2026, U.S. District Judge Joshua D. Wolson made several key summary judgment rulings in advance of trial in ...

Agriculture Minister John Steenhuisen visited the Agricultural Research Council’s (ARC) Onderstepoort Veterinary Research (OVR) campus for the handover of the first locally produced foot-and-mouth ...

A world-first trial in Australia will treat children with advanced brain cancer using technology from the COVID-19 jab.